Pathology News

Joshua Warrick, MD, will join the Department of Pathology as a professor of pathology and senior research scientist on July 1, succeeding Peter Humphrey, MD, PhD, as director of genitourinary pathology.

Yale Cancer Center and Smilow Cancer Hospital scientists, physicians, and trainees presented research studies at the 2025 Annual Meeting of the Society of Surgical Oncology March 27-29 in Tampa, Florida. The program featured a range of impactful cancer research and clinical translation lectures, posters, and case discussions.

Yale New Haven Hospital has made a major breakthrough for reconstructive and lymphatic surgery patients by becoming the first in New England and fifth center in the United States to use the Symani Surgical System robot.

Faculty, Residents, and Clinical Fellows from Yale Pathology had a strong presence at USCAP 2025, the 114th annual meeting of the United States and Canadian Academy of Pathology, held March 22 to 27 in Boston.

A new study co-led by scientists at Yale and NYU reveals a novel mechanism linking genetic mutations and cancer drug efficacy. 

The American Association for the Advancement of Science has elected eight Yale faculty members as part of its latest class of fellows.

A new study from scientists at Yale School of Medicine has identified N-acetyltransferase 10 (NAT10), an enzyme highly expressed in brain metastasis, as a driver of brain metastasis. NAT10 primarily functions by adding acetyl groups to RNA molecules, regulating their function, stability or translation.

This Yale research, published in Science Signaling on March 25, offers new findings that could help improve therapies for glioblastoma and other aggressive cancers that are difficult to treat.

The Yale Department of Pathology is pleased to welcome nine new residents on Match Day 2025.